AP9528a-ev
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
AP9528a
|
Abcepta, Inc.
|
CHMP4B [N-term] [RB24088], Rabbit Polyclonal Antibody
|
Human
|
FC, IHC-P, WB
|
|
AP9856c-ev
|
Abcepta, Inc.
|
K2C78 [Centre] [RB24916], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
AP9856c
|
Abcepta, Inc.
|
K2C78 [Centre] [RB24916], Rabbit Polyclonal Antibody
|
Human
|
FC, WB
|
|
AP19254b-ev
|
Abcepta, Inc.
|
TMED10 [C-term] [RB40979], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP19254b
|
Abcepta, Inc.
|
TMED10 [C-term] [RB40979], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP16626c-ev
|
Abcepta, Inc.
|
TMED6 [Centre] [RB36101], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AP16626c
|
Abcepta, Inc.
|
TMED6 [Centre] [RB36101], Rabbit Polyclonal Antibody
|
Human
|
WB
|
|
AM2262b-ev
|
Abcepta, Inc.
|
VCP [1344CT150.163.114], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
IF, WB
|
|
AM2262b
|
Abcepta, Inc.
|
VCP [1344CT150.163.114], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
IF, WB
|
|
AM8494b-ev
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
AM8494b
|
Abcepta, Inc.
|
VCP [1563CT163.48.77], Mouse Monoclonal Antibody
|
Human, Mouse, Rat
|
WB, IHC-P, FC, IF
|
|
HY-P9968-1mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
HY-P9968-5mg
|
MedChemexpress LLC
|
Nimotuzumab [CAS 780758-10-3]
|
|
Cancer-Kinase/protease
|
|
HY-P99756-1mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
HY-P99756-10mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
HY-P99756-5mg
|
MedChemexpress LLC
|
Nirsevimab [CAS 1989556-22-0]
|
|
COVID-19-anti-virus
|
|
HY-P99763-1mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
HY-P99763-10mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
HY-P99763-5mg
|
MedChemexpress LLC
|
Ociperlimab [CAS 2342597-93-5]
|
|
|
|
HY-P9950-1mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-P9950-5mg
|
MedChemexpress LLC
|
Omalizumab [CAS 242138-07-4]
|
|
COVID-19-immunoregulation
|
|
HY-P99406-1mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
HY-P99406-10mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|
HY-P99406-5mg
|
MedChemexpress LLC
|
Petosemtamab [CAS 2213450-26-9]
|
|
Cancer-Kinase/protease
|
|